Cytek Biosciences (NASDAQ:CTKB) Releases Quarterly Earnings Results
Cytek Biosciences (NASDAQ:CTKB – Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.07), FiscalAI reports. Cytek Biosciences had a negative return on equity of 9.81% and a negative net margin of 36.25%.The business had revenue [...]
ONLY AVAILABLE IN PAID PLANS
Published by: tickerreport
Read full article here: https://www.tickerreport.com/banking-finance/13435452/cytek-biosciences-nasdaqctkb-releases-quarterly-earnings-results.html
- Ctkb
- Cytek Biosciences
- Earnings
- Nasdaq:ctkb
- Medical
- Max Byerly
- Business
- United States Of America
